Sun Pharma will be responsible for pursuing regulatory approvals in licensed territories where approval has not yet been ...

Sun Pharma will commercialise and manufacture LIB Therapeutics' once-monthly cholesterol drug outside the US and China after ...

Pharma stocks outperform: While Sensex has lost 13%, Nifty pharma index has gained 18% this year.

Sun Pharma will be responsible for pursuing regulatory approvals in licensed territories where approval has not yet been obtained. The excluded China territory comprises mainland China, Hong Kong, ...

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715; together with its subsidiaries and/or associated companies, "Sun Pharma") and LIB Therapeutics ...

Sun Pharma is teaming up with fashion designer Christian Siriano for a new educational campaign focused on the positives of ...

Sun Pharmaceutical Industries Ltd. 524715 +1.77% shares advanced 1.77% to 1,868.00 Indian rupees Monday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...

Sun Pharma inks exclusive licensing with LIB Therapeutics to commercialize lerodalcibep worldwide (excluding U.S. and China) ...

Sun Pharma Advanced Research Company Limited is an India-based clinical-stage biopharmaceutical company that focuses on developing therapeutics to improve standards of care for pa ...

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and ...

See how Sun Pharma’s global lerodalcibep deal and EU-approved Lyrokaul expand LDL cholesterol treatment options outside the ...

Sun Pharmaceutical Industries Ltd. 524715 -0.38% shares inched down 0.38% to 1,835.00 Indian rupees Tuesday, on what proved to be an all-around poor trading session for the stock market, with the BSE ...